Operating Lease, Right-of-Use Asset of Enliven Therapeutics, Inc. from 31 Mar 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Enliven Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2021 to 31 Dec 2025.
  • Enliven Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $383,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Enliven Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $383,000 +$383,000 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $475,000 +$394,000 +486% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $564,000 +$403,000 +250% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $651,000 +$410,000 +170% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $0 -$320,000 -100% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 $81,000 -$317,000 -80% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $161,000 -$314,000 -66% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $241,000 -$310,000 -56% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $320,000 -$306,000 -49% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $398,000 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $475,000 +$345,000 +265% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $551,000 -$1,760,000 -76% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $626,000 +$164,000 +35% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q2 2022 $130,000 -$507,000 -80% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $2,311,000 +$1,617,000 +233% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $462,000 31 Dec 2021 8-K 23 Jun 2023
Q3 2021 $580,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $637,000 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $694,000 31 Mar 2021 10-Q 11 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.